百济神州:ADAM9 ADC申报IND

医药笔记
Mar 03

▎Armstrong2026年3月2日,百济神州注射用BG-C0979的临床试验申请获得受理。今年2月,百济神州已在Clinicaltrials.gov网站上注册了BG-0979治疗晚期实体瘤的一期临床试验。该一期临床计划入组84例晚期实体瘤患者,同时探索单药治疗和PD-1抗体联合治疗的临床方案。从临床注册信息判断,BG-C0979应为一款ADAM9 ADC,采用TOP1i作为payload。总结...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10